DCC-3014(Vimseltinib)|CAS 1628606-05-2|DC Chemicals

Cas No.:	1628606-05-2
Chemical Name:	DCC-3014
Synonyms:	DCC-3014
SMILES:	O=C1N(C)C(NC(C)C)=NC=C1C2=NC(C)=C(OC3=CC(C4=CN(C)N=C4)=NC=C3)C=C2
Formula:	C₂₃H₂₅N₇O₂
M.Wt:	431.49
Purity:	>98%
Sotrage:	Please store the product under the recommended conditions in the Certificate of Analysis.
Publication:	[1]. Yumi Ahn, et al. 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities. WO2014145025A2.

Description:	DCC-3014(Vimseltinib) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of <0.01 μM and 0.1-1 μM, respectively.
Target:	IC50: <0.01 μM (c-FMS/CSF-IR), 0.1-1 μM (c-Kit)[1]
In Vitro:	DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor with anti-cancer and anti-proliferative activities[1].
References:	[1]. Yumi Ahn, et al. 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities. WO2014145025A2.

Cat. No.	Product name	Field of application
DC40860	DCC-3014(Vimseltinib)	DCC-3014(Vimseltinib) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of <0.01 μM and 0.1-1 μM, respectively.